Disclosure of notification received from Alychlo

Core Points - Fagron received a notification from Alychlo NV regarding a change in shareholding that crossed the disclosure threshold of 3% downwards [1][8] - The notification indicates that Alychlo NV disposed of voting securities or voting rights on 25 July 2024, resulting in a new holding of 2,139,886 voting rights [8] - The total number of voting rights at that time was 73,228,904, meaning Alychlo NV and Marc Coucke together held 2.93% of the total voting rights [8] Company Information - Fagron is a leading global company in pharmaceutical compounding, providing personalized medicine to hospitals, pharmacies, clinics, and patients in over 30 countries [3] - The company is registered in Nazareth and listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR' [4] - Operational activities are managed by Fagron BV, headquartered in Rotterdam [4]